What is LABT's dilution risk score?

LABT has a latest available DilutionScore record of 61/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for LABT, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for LABT?

DilutionWatch tracks 25 SEC filing types for LABT including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect LABT shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For LABT, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for LABT tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for LABT. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

LABT Dilution Risk Score: 61/100

Score Breakdown

📋 Offering Ability

60

💰 Cash Runway

40

📊Float Risk—

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 5%

📉 Score Deterioration model 10%

• Score in HIGH risk zone (61/100)

🔔 Track LABT — Get forecast alerts →

Market Data

Market CapN/A

Shares Outstanding2.37M

FloatN/A

Cash$4.58M

DebtN/A

Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

Field	Current Value	Basis
DilutionScore	61/100	DilutionWatch score record
Shares Outstanding	2.37M	Verified float table or market cache
Public Float	Not available	Verified float table or market cache
Market Cap	Not available	Market data cache
Cash Runway	Not available	DilutionWatch score inputs
Shelf Capacity	None in current score inputs	SEC-derived dilution fields
ATM Capacity	None in current score inputs	SEC-derived dilution fields
Outstanding Warrants	None in current score inputs	SEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 5.

Recent SEC source mix: 424B3 2, SC 13G 3.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

4.2% institutional ownership

Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers

🔔 Track LABT for full holder detail →

Short Interest

Short Interest126.1K

Days to Cover1.0

% of FloatN/A

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

SC 13G BENEFICIAL OWNERSHIP 2026-08-14

SC 13G BENEFICIAL OWNERSHIP 2026-08-06

SC 13G BENEFICIAL OWNERSHIP 2026-06-23

424B3 ATM 2026-06-22

Full SEC filing analysis available with free account →

Recent News

Lakewood-Amedex Biotherapeutics to Present at H.C. Wainwright 28th Annual Global PR Newswire · Sep 08

LABT: Advancing Toward Phase 2a Study of Nu-3 in Infected Diabetic Foot Ulcers Zacks Small Cap Research · Aug 26

Lakewood-Amedex Biotherapeutics Becomes a B2i Digital Featured Company NewMediaWire · Aug 25

Factual LABT Dilution Snapshot

Lakewood-Amedex Biotherapeutics Inc. (LABT) has a DilutionScore of 61/100, rated High dilution risk. Score date: September 09, 2026.

Recent SEC activity tracked for LABT: SC 13G on 2026-08-14; SC 13G on 2026-08-06; SC 13G on 2026-06-23.
Score coverage note: Float Risk is excluded because public-float data is unavailable.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,335+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

Float Risk is excluded because public-float data is unavailable.

LABT — Lakewood-Amedex Biotherapeutics Inc. Dilution Risk Tracker